Slough, UK, and Richmond, VA, April 25, 2023 – Indivior PLC (LSE: INDV) today announced that it will participate in the following investor event:
- Bank of America Global Healthcare Conference 2023 – Las Vegas
Mark Crossley, CEO, will host 1x1/group meetings on Wednesday and Thursday, May 10th and 11th and host a presentation Wednesday May 10th at 5:00 p.m. US PDT (8:00 p.m. US EST). Investors can contact their Bank of America representative to schedule a meeting. The presentation will be available at www.indivior.com and can also be viewed using the following webcast link: https://bofa.veracast.com/webcasts/bofa/healthcare2023/idvYkp0I.cfm
About Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to
treat substance use disorders (SUD) and serious mental illnesses. Our vision is that all patients around the world
will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 1,000 individuals globally and its portfolio of products is available in 39 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.
Contact:
Jason Thompson
Vice President, Investor Relations
Tel: 804-402-7123 or jason.thompson@indivior.com
Tim Owens
Director, Investor Relations
Tel: 804-263-3978 or timothy.owens@indivior.com
Share